An illustration showing how, when the modified oncolytic virus enters cancer cells, it causes the tumor cells to rupture while also releasing the compound that blocks TGF-beta. The rupturing of the tumor cells draws the attention of T cells, which can attack the tumor cells more effectively because TGF-beta and other regulatory T cells in the tumor have been disabled by the oncolytic virus's payload.